Aptose Biosciences Q3 EPS $(0.12) Beats $(0.14) Estimate

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 25 percent increase over losses of $(0.16) per share from

Benzinga · 11/05/2019 21:04

Aptose Biosciences (NASDAQ:APTO) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 25 percent increase over losses of $(0.16) per share from the same period last year.